BioKDE: Biomedical Knowledge Discovery Engine

Contact Us Login
Sorted by:  
Results by Year
Article Type
Publication date
  2,181,048 results (0.578 seconds)
1
Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy.
Zeina N Al-Mahayri,  George P Patrinos,  Bassam R Ali.
Front Pharmacol. 2020 Apr 15; 11:445. PMID: 32351390     Free PMC article
Review.
2
Breast cancer chemotherapy.
Heather L McArthur,  Clifford A Hudis.
Cancer J. 2007 Jul 11; 13(3):141-7. PMID: 17620762
Review.
3
Fatty acids: Adiposity and breast cancer chemotherapy, a bad synergy?
Ilze Mentoor,  A-M Engelbrecht,  Theo Nell.
Prostaglandins Leukot Essent Fatty Acids. 2018 Nov 22; 140:18-33. PMID: 30553399
Review.
4
Development of Innovative Formulations for Breast Cancer Chemotherapy.
Ana Isabel Fraguas-Sánchez,  Ana Isabel Torres-Suárez.
Cancers (Basel). 2020 Nov 06; 12(11):. PMID: 33171899     Free PMC article
5
Prevalence of xerostomia in women during breast cancer chemotherapy.
Vânia Lopes Pinto, Suzete Maria Fustinoni, +2 authors, Simone Elias.
Rev Bras Enferm. 2020 Sep 21; 73(suppl 4):e20190785. PMID: 32965427
6
Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System.
Taurean Brown,  DeLawrence Sykes,  Antiño R Allen.
Biomedicines. 2021 Feb 13; 9(2):. PMID: 33668580     Free PMC article
Review.
7
ID4 Promotes Breast Cancer Chemotherapy Resistance via CBF1-MRP1 Pathway.
Xi Zhang, Guangyan Gu, +10 authors, Jiawen Xu.
J Cancer. 2020 Apr 06; 11(13):3846-3857. PMID: 32328189     Free PMC article
8
[Advances in breast cancer chemotherapy].
Takashi Ishikawa, Satoru Shimizu, +2 authors, Hiroshi Shimada.
Nihon Rinsho. 2006 Mar 15; 64(3):529-35. PMID: 16529045
Review.
9
Breast cancer chemotherapy-related cognitive dysfunction.
Tim A Ahles,  Andrew J Saykin.
Clin Breast Cancer. 2003 Jan 21; 3 Suppl 3:S84-90. PMID: 12533268
Review.
10
Systemic treatment for breast cancer: chemotherapy and biotherapy agents.
Laura Bourdeanu,  Ellen A Liu.
Semin Oncol Nurs. 2015 Feb 16; 31(2):156-62. PMID: 25951744
Review.
11
Thyroid function following breast cancer chemotherapy: A systematic review.
Keywan Mortezaee, Amirhossein Ahmadi, +6 authors, Amirhossein Sahebkar.
J Cell Biochem. 2019 Apr 25; 120(8):12101-12107. PMID: 31021464
Systematic Review.
12
Persistent Impairment in Cardiopulmonary Fitness after Breast Cancer Chemotherapy.
Stephen J Foulkes, Erin J Howden, +8 authors, Andre LA Gerche.
Med Sci Sports Exerc. 2019 Mar 05; 51(8):1573-1581. PMID: 30829962
13
[Medical treatment of breast cancer: chemotherapy and tailored therapy].
Florence Dalenc.
Rev Prat. 2014 Mar 04; 63(10):1408-14. PMID: 24579340
Review.
14
Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.
Sharon Marsh,  Geoffrey Liu.
Adv Drug Deliv Rev. 2008 Dec 03; 61(5):381-7. PMID: 19100797
Review.
15
[Role of G-CSF for breast cancer chemotherapy].
Yasuhiro Suzuki,  Yuki Saito,  Yutaka Tokuda.
Nihon Rinsho. 2007 Aug 08; 65 Suppl 6:572-4. PMID: 17679213
Review.
16
Premenopausal breast cancer: chemotherapy and endocrine therapy.
Herbert G Sayer,  Roland Kath,  Kay-Oliver Kliche,  Klaus Höffken.
Drugs. 2002 Sep 25; 62(14):2025-38. PMID: 12269848
Review.
17
Sclerosing canaliculitis after 5-fluorouracil breast cancer chemotherapy.
V Lee,  C R Bentley,  J M Olver.
Eye (Lond). 1998 Oct 17; 12 ( Pt 3a):343-9. PMID: 9775228
Review.
18
Lapatinib-loaded acidity-triggered charge switchable polycarbonate-doxorubicin conjugate micelles for synergistic breast cancer chemotherapy.
Zhihao Guo, Enhui Liang, +6 authors, Yujiang Fan.
Acta Biomater. 2020 Oct 10; 118:182-195. PMID: 33045399
19
[Utility of Prophylactic Administration of Pegfilgrastim in Breast Cancer Chemotherapy].
Shoko Norimura, Keiichi Kontani, +7 authors, Hiroyasu Yokomise.
Gan To Kagaku Ryoho. 2018 Dec 28; 45(12):1729-1732. PMID: 30587729
20
Pharmacokinetics of anti-cancer drugs used in breast cancer chemotherapy.
Swati Nagar.
Adv Exp Med Biol. 2010 Aug 27; 678:124-32. PMID: 20738014
Review.
1 2 3 4 5 6 7 8 9 10 Next